查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1673943

EPA 和 DHA 市场按来源、形式、用途和地区划分

EPA and DHA Market, By Source, By Form, By Application, By Geography
出版日期: | 出版商: Coherent Market Insights | 英文 153 Pages | 商品交期: 2-3个工作天内

价格
简介目录

预计 2025 年全球 EPA 和 DHA 市场规模为 20.7 亿美元，2032 年将达到 33.2 亿美元，2025 年至 2032 年的年复合成长率为 7.0%。

报告范围 报告详细信息
基准年 2024 2025 年市场规模 20.7亿美元
效能资料 2020-2024 预测期 2025-2032
预测期：2025 年至 2032 年复合年增长率 7.00％ 2032 年金额预测 33.2亿美元
数字。 EPA 和 DHA 市场区域份额（%）（2025 年）
EPA 和 DHA 市场-IMG1

由于消费者健康意识的增强以及含有这些关键的Omega-3脂肪酸的补充剂的普及，全球 EPA 和 DHA 市场正在经历显着增长。 EPA 和 DHA 是源自海洋的多不饱和脂肪酸，对大脑、眼睛和心血管健康发挥重要作用。随着老龄化社会的推进，文明病的蔓延推动了对 EPA 和 DHA 补充剂的需求增加。各种临床研究已经证明了 EPA 和 DHA 的深远益处，包括减少发炎、降低心臟病的风险和改善神经功能。随着科学证据的增加，越来越多的人从食物和补充剂中获得这些必需脂肪酸。

市场动态

随着消费者对 EPA 和 DHA 的健康益处以及慢性病流行的认识不断提高，推动了 EPA 和 DHA 补充剂的全球销售。然而，原材料采购成本高对市场进入者来说是一个重大挑战。鱼油的充足供应和Omega-3脂肪酸的素食替代品的出现为市场扩张提供了有利可图的机会。持续研究和开发新的应用可能会扩大 EPA 和 DHA 的临床用途和市场范围。

研究的主要特点

本报告对全球 EPA 和 DHA 市场进行了详细分析，并提供了预测期（2025-2032 年）的市场规模（十亿美元）和年复合成长率（CAGR%），假设基准年为 2024 年。

它还揭示了各个领域的潜在商机，并解释了该市场有吸引力的投资提案矩阵。

它还提供了对市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景以及主要企业采用的竞争策略的重要见解。

全球 EPA 和 DHA 市场的主要企业是根据公司亮点、产品系列、关键亮点、财务表现和策略等参数进行的分析。

研究中介绍的主要企业包括荷兰皇家帝斯曼集团 (Koninklijke DSM NV)、KD Pharma Group、阿彻丹尼尔斯米德兰公司 (The Archer Daniels Midland Company)、Corbion NV、Novasep Holding SAS、Neptune Wellness Solutions、 BASF SE、Omegas Ltd. operative Group Limited)。

本报告的见解将使负责人和公司经营团队能够就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。

全球 EPA 和 DHA 市场报告迎合了该行业的各个相关人员，包括投资者、供应商、产品製造商、经销商、新进业者和金融分析师。

预计相关人员将透过分析全球 EPA 和 DHA 市场所使用的各种策略矩阵来促进他们的决策。

目录

第一章 调查目的与前提条件

  • 研究目标
  • 先决条件
  • 简称

第二章 市场展望

  • 报告描述
    • 市场定义和范围
  • 执行摘要

第三章市场动态、法规与趋势分析

  • 市场动态
  • 影响分析
  • 监管情景
  • 产品发布/核准
  • PEST分析
  • 波特分析
  • 市场机会
  • 监管情景
  • 产业趋势

4. 2020 年至 2032 年全球 EPA 与 DHA 市场来源分布（十亿美元）

  • 介绍
  • 鱼油
  • 藻油
  • 磷虾油
  • 其他的

5. 2020 年至 2032 年全球 EPA 和 DHA 市场（按形式划分）（十亿美元）

  • 介绍
  • 液体
  • 胶囊和软胶囊
  • 粉末
  • 其他的

6. 2020 年至 2032 年全球 EPA 和 DHA 市场（按应用划分）（十亿美元）

  • 介绍
  • 营养补充品
  • 饮食
  • 药品
  • 其他的

7. 2020 年至 2032 年全球 EPA 和 DHA 市场（按地区划分）（十亿美元）

  • 介绍
  • 北美洲
  • 拉丁美洲
  • 欧洲
  • 亚太地区
  • 中东
  • 非洲

第八章 竞争格局

  • Koninklijke DSM NV
  • KD Pharma Group
  • The Archer Daniels Midland Company
  • Corbion NV
  • Novasep Holding SAS
  • Neptune Wellness Solutions
  • BASF SE
  • Omega Protein Corporation
  • Croda International PLC
  • Novotech Nutraceuticals
  • Herbalife Nutrition Ltd.
  • Fonterra Co-operative Group Limited

第 9 章分析师建议

  • 兴衰
  • 一致的机会地图

第十章参考文献与调查方法

  • 参考
  • 调查方法
  • 关于出版商
简介目录
Product Code: CMI5200

Global EPA and DHA Market is estimated to be valued at USD 2.07 Bn in 2025 and is expected to reach USD 3.32 Bn by 2032, growing at a compound annual growth rate (CAGR) of 7.0% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 2.07 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 7.00% 2032 Value Projection: USD 3.32 Bn
Figure. EPA And DHA Market Share (%), By Region 2025
EPA and DHA Market - IMG1

Global EPA and DHA market has been witnessing significant growth due to rising health consciousness among consumers and growing adoption of supplements containing these key omega-3 fatty acids. EPA and DHA are polyunsaturated fatty acids found in marine sources that play an important role in brain and eye health as well as cardiovascular health. Increasing prevalence of lifestyle diseases along with growing aging population has boosted the demand for EPA and DHA supplements. Various clinical studies have demonstrated the far-ranging benefits of EPA and DHA in reducing inflammation, lowering risk of heart disease, and improving neurological functioning. With growing scientific evidence, more people are incorporating these essential fatty acids into their diets through food sources as well as supplements.

Market Dynamics

Increasing consumer awareness about EPA and DHA health benefits and prevalence of chronic diseases boosts sales of EPA and DHA supplements globally. However, high procurement cost of raw materials poses major challenge for market players. Abundant availability of fish oils as well as emergence of alternative vegan sources of omega-3 fatty acids present lucrative opportunities for the market expansion. Sustained R&D into new applications can expand the clinical uses and market outreach of EPA and DHA.

Key Features of the Study

This report provides in-depth analysis of the global EPA and DHA market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global EPA and DHA market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Koninklijke DSM NV, KD Pharma Group, The Archer Daniels Midland Company, Corbion NV, Novasep Holding SAS, Neptune Wellness Solutions, BASF SE, Omega Protein Corporation, Croda International PLC, Novotech Nutraceuticals, Herbalife Nutrition Ltd., and Fonterra Co-operative Group Limited

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

Global EPA and DHA market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global EPA and DHA market

Market Segmentation

  • By Source Insights (Revenue, USD Bn, 2020 - 2032)
    • Fish Oil
    • Algal Oil
    • Krill Oil
    • Others
  • By Form Insights (Revenue, USD Bn, 2020 - 2032)
    • Liquid
    • Capsules and Soft gels
    • Powder
    • Others
  • By Application Insights (Revenue, USD Bn, 2020 - 2032)
    • Dietary Supplements
    • Food and Beverages
    • Pharmaceuticals
    • Others
  • Regional Insights (Revenue, USD Bn, 2020 - 2032)
    • North America
    • U.S.
    • Canada
    • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
    • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Key Players Insights
    • Koninklijke DSM NV
    • KD Pharma Group
    • The Archer Daniels Midland Company
    • Corbion NV
    • Novasep Holding SAS
    • Neptune Wellness Solutions
    • BASF SE
    • Omega Protein Corporation
    • Croda International PLC
    • Novotech Nutraceuticals
    • Herbalife Nutrition Ltd.
    • Fonterra Co-operative Group Limited

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Global EPA and DHA Market, By Source
    • Global EPA and DHA Market, By Form
    • Global EPA and DHA Market, By Application
    • Global EPA and DHA Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Market Opportunities
  • Regulatory Scenario
  • Key Developments
  • Industry Trend

4. Global EPA and DHA Market, By Source, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Fish Oil
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Algal Oil
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Krill Oil
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

5. Global EPA and DHA Market, By Form, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Liquid
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Capsules and Soft gels
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Powder
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global EPA and DHA Market, By Application, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Dietary Supplements
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Food and Beverages
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Pharmaceuticals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global EPA and DHA Market, By Region, 2020 - 2032, (USD Bn)

  • Introduction
    • Market Share (%) Analysis, 2025, 2028 & 2032, (USD Bn)
    • Market Y-o-Y Growth Analysis (%), 2021 - 2032, (USD Bn)
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, By Source, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, By Form, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, (USD Bn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, By Source, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, By Form, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, (USD Bn)
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, By Source, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, By Form, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, (USD Bn)
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, By Source, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, By Form, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, (USD Bn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, By Source, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, By Form, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, (USD Bn)
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, By Source, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, By Form, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, By Country/Region, 2020 - 2032, (USD Bn)
      • South Africa
      • North Africa
      • Central Africa

8. Competitive Landscape

  • Koninklijke DSM NV
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • KD Pharma Group
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • The Archer Daniels Midland Company
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Corbion NV
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Novasep Holding SAS
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Neptune Wellness Solutions
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • BASF SE
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Omega Protein Corporation
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Croda International PLC
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Novotech Nutraceuticals
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Herbalife Nutrition Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Fonterra Co-operative Group Limited
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies

9. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

10. References and Research Methodology

  • References
  • Research Methodology
  • About us